Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Molecular Endocrinology (Baltimore, Md.)
|
July 25, 2009
Isoform-specific transcriptional activity of overlapping target genes that respond to thyroid hormone receptors alpha1 and beta1
Ivan H Chan, Martin L Privalsky
Molecular Cancer Research : MCR
|
January 8, 2010
A conserved lysine in the thyroid hormone receptor-alpha1 DNA-binding domain, mutated in hepatocellular carcinoma, serves as a sensor for transcriptional regulation
Ivan H Chan, Martin L Privalsky
Molecular Endocrinology (Baltimore, Md.)
|
May 31, 2011
Mutant thyroid hormone receptors (TRs) isolated from distinct cancer types display distinct target gene specificities: a unique regulatory repertoire associated with two renal clear cell carcinomas
Meghan D Rosen, Ivan H Chan, Martin L Privalsky
Thyroid : Official Journal of the American Thyroid Association
|
June 27, 2008
A cautionary note as to the use of pBi-L and related luciferase/transgenic vectors in the study of thyroid endocrinology
Ivan H Chan, Alexander D Borowsky, Martin L Privalsky
Molecular Endocrinology (Baltimore, Md.)
|
May 31, 2011
A mechanism for pituitary-resistance to thyroid hormone (PRTH) syndrome: a loss in cooperative coactivator contacts by thyroid hormone receptor (TR)beta2
Sangho Lee, Briana M Young, Wei Wan, et al.
Receptors & Clinical Investigation
|
December 15, 2015
IL-10: Expanding the Immune Oncology Horizon
Ivan H Chan, Victoria Wu, Scott McCauley, et al.
The Journal of Biological Chemistry
|
June 3, 2009
The p160 coactivator PAS-B motif stabilizes nuclear receptor binding and contributes to isoform-specific regulation by thyroid hormone receptors
Martin L Privalsky, Sangho Lee, Johnnie B Hahm, et al.
Cancer Research
|
May 15, 2012
IL-10 directly activates and expands tumor-resident CD8(+) T cells without de novo infiltration from secondary lymphoid organs
Jan Emmerich, John B Mumm, Ivan H Chan, et al.
Oncoimmunology
|
September 14, 2016
PEG-rIL-10 treatment decreases FoxP3(+) Tregs despite upregulation of intratumoral IDO
Ivan H Chan, Victoria Wu, Melissa Bilardello, et al.
Plos One
|
June 15, 2016
PEGylated IL-10 Activates Kupffer Cells to Control Hypercholesterolemia
Ivan H Chan, Dennis Van Hoof, Marina Abramova, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Molecular Endocrinology (Baltimore, Md.)
|
July 25, 2009
Isoform-specific transcriptional activity of overlapping target genes that respond to thyroid hormone receptors alpha1 and beta1
Ivan H Chan, Martin L Privalsky
Molecular Cancer Research : MCR
|
January 8, 2010
A conserved lysine in the thyroid hormone receptor-alpha1 DNA-binding domain, mutated in hepatocellular carcinoma, serves as a sensor for transcriptional regulation
Ivan H Chan, Martin L Privalsky
Molecular Endocrinology (Baltimore, Md.)
|
May 31, 2011
Mutant thyroid hormone receptors (TRs) isolated from distinct cancer types display distinct target gene specificities: a unique regulatory repertoire associated with two renal clear cell carcinomas
Meghan D Rosen, Ivan H Chan, Martin L Privalsky
Thyroid : Official Journal of the American Thyroid Association
|
June 27, 2008
A cautionary note as to the use of pBi-L and related luciferase/transgenic vectors in the study of thyroid endocrinology
Ivan H Chan, Alexander D Borowsky, Martin L Privalsky
Molecular Endocrinology (Baltimore, Md.)
|
May 31, 2011
A mechanism for pituitary-resistance to thyroid hormone (PRTH) syndrome: a loss in cooperative coactivator contacts by thyroid hormone receptor (TR)beta2
Sangho Lee, Briana M Young, Wei Wan, et al.
Receptors & Clinical Investigation
|
December 15, 2015
IL-10: Expanding the Immune Oncology Horizon
Ivan H Chan, Victoria Wu, Scott McCauley, et al.
The Journal of Biological Chemistry
|
June 3, 2009
The p160 coactivator PAS-B motif stabilizes nuclear receptor binding and contributes to isoform-specific regulation by thyroid hormone receptors
Martin L Privalsky, Sangho Lee, Johnnie B Hahm, et al.
Cancer Research
|
May 15, 2012
IL-10 directly activates and expands tumor-resident CD8(+) T cells without de novo infiltration from secondary lymphoid organs
Jan Emmerich, John B Mumm, Ivan H Chan, et al.
Oncoimmunology
|
September 14, 2016
PEG-rIL-10 treatment decreases FoxP3(+) Tregs despite upregulation of intratumoral IDO
Ivan H Chan, Victoria Wu, Melissa Bilardello, et al.
Plos One
|
June 15, 2016
PEGylated IL-10 Activates Kupffer Cells to Control Hypercholesterolemia
Ivan H Chan, Dennis Van Hoof, Marina Abramova, et al.
Page
of 2